These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 23664882

  • 1. Superior renoprotective effects of the combination of breviscapine with enalapril and its mechanism in diabetic rats.
    Xu XX, Zhang W, Zhang P, Qi XM, Wu YG, Shen JJ.
    Phytomedicine; 2013 Jul 15; 20(10):820-7. PubMed ID: 23664882
    [Abstract] [Full Text] [Related]

  • 2. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
    Wu YG, Lin H, Qian H, Zhao M, Qi XM, Wu GZ, Lin ST.
    Inflamm Res; 2006 May 15; 55(5):192-9. PubMed ID: 16830106
    [Abstract] [Full Text] [Related]

  • 3. Renoprotective effect of breviscapine through suppression of renal macrophage recruitment in streptozotocin-induced diabetic rats.
    Qi XM, Wu GZ, Wu YG, Lin H, Shen JJ, Lin SY.
    Nephron Exp Nephrol; 2006 May 15; 104(4):e147-57. PubMed ID: 16902319
    [Abstract] [Full Text] [Related]

  • 4. Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats.
    Kalender B, Oztürk M, Tunçdemir M, Uysal O, Dagistanli FK, Yegenaga I, Erek E.
    Acta Histochem; 2002 May 15; 104(2):123-30. PubMed ID: 12086332
    [Abstract] [Full Text] [Related]

  • 5. Prevention of early renal injury by mycophenolate mofetil and its mechanism in experimental diabetes.
    Wu YG, Lin H, Qi XM, Wu GZ, Qian H, Zhao M, Shen JJ, Lin ST.
    Int Immunopharmacol; 2006 Mar 15; 6(3):445-53. PubMed ID: 16428080
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin-converting enzyme inhibition and angiotensin AT1 receptor blockade downregulate angiotensin-converting enzyme expression and attenuate renal injury in streptozotocin-induced diabetic rats.
    Motawi TK, El-Maraghy SA, Senousy MA.
    J Biochem Mol Toxicol; 2013 Jul 15; 27(7):378-87. PubMed ID: 23733546
    [Abstract] [Full Text] [Related]

  • 7. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A, Veksler S, Gafter U, Boner G, Wittenberg C, van Dijk DJ.
    J Renin Angiotensin Aldosterone Syst; 2004 Sep 15; 5(3):146-51. PubMed ID: 15526251
    [Abstract] [Full Text] [Related]

  • 8. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.
    Kang YS, Ko GJ, Lee MH, Song HK, Han SY, Han KH, Kim HK, Han JY, Cha DR.
    Nephrol Dial Transplant; 2009 Jan 15; 24(1):73-84. PubMed ID: 18682491
    [Abstract] [Full Text] [Related]

  • 9. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA, da Silva CG, Costa RS, Coimbra TM.
    Diabetes Metab Res Rev; 2003 Jan 15; 19(1):43-51. PubMed ID: 12592643
    [Abstract] [Full Text] [Related]

  • 10. Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist.
    Kakizawa H, Itoh Y, Imamura S, Matsumoto T, Ishiwata Y, Ono Y, Yamamoto K, Kato T, Hayakawa N, Oda N, Goto Y, Goto Y, Nagasaka A, Senda T, Itoh M.
    Horm Metab Res; 2004 Jul 15; 36(7):458-64. PubMed ID: 15305228
    [Abstract] [Full Text] [Related]

  • 11. Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats.
    Ahmed OM, Ali TM, Abdel Gaid MA, Elberry AA.
    PLoS One; 2019 Jul 15; 14(9):e0214349. PubMed ID: 31527864
    [Abstract] [Full Text] [Related]

  • 12. Prevention of early liver injury by breviscapine in streptozotocin-induced diabetic rats.
    Wu YG, Xia LL, Lin H, Zhou D, Qian H, Lin ST.
    Planta Med; 2007 May 15; 73(5):433-8. PubMed ID: 17566145
    [Abstract] [Full Text] [Related]

  • 13. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.
    Qin J, Zhang Z, Liu J, Sun L, Hu L, Cooper ME, Cao Z.
    Kidney Int; 2003 Aug 15; 64(2):565-71. PubMed ID: 12846751
    [Abstract] [Full Text] [Related]

  • 14. Renoprotective effects of (+)-catechin in streptozotocin-induced diabetic rat model.
    Chennasamudram SP, Kudugunti S, Boreddy PR, Moridani MY, Vasylyeva TL.
    Nutr Res; 2012 May 15; 32(5):347-56. PubMed ID: 22652374
    [Abstract] [Full Text] [Related]

  • 15. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH, Feng L, Zhu MM, Gu JF, Jiang J, Cheng XD, Ding SM, Wu C, Jia XB.
    J Ethnopharmacol; 2014 May 15; 151(1):591-600. PubMed ID: 24269777
    [Abstract] [Full Text] [Related]

  • 16. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):264-71. PubMed ID: 18582458
    [Abstract] [Full Text] [Related]

  • 17. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 18. Effect of catalpol on diabetic nephropathy in rats.
    Dong Z, Chen CX.
    Phytomedicine; 2013 Aug 15; 20(11):1023-9. PubMed ID: 23746755
    [Abstract] [Full Text] [Related]

  • 19. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R, Futterweit S, Valderrama E, Tarectecan AA, Bylander JE, Bond JS, Trachtman H.
    Am J Physiol Renal Physiol; 2005 Oct 15; 289(4):F911-21. PubMed ID: 15942051
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin converting enzyme inhibitor suppresses glomerular transforming growth factor beta receptor expression in experimental diabetes in rats.
    Hill C, Logan A, Smith C, Grønbaek H, Flyvbjerg A.
    Diabetologia; 2001 Apr 15; 44(4):495-500. PubMed ID: 11357481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.